Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Genetic Contribution to Drug Induced Renal Injury: The Drug Induced Renal Injury Consortium (DIRECT)

NCT02159209 is registered in ClinicalTrials.gov with Ravindra Mehta as lead sponsor.

NCT NCT02159209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02159209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Genetic Contribution to Drug Induced Renal Injury: The Drug Induced Renal Injury Consortium (DIRECT)
Lead sponsor
Ravindra Mehta
Phase
Observational
Overall status
Completed
Start date
February 28, 2013
Completion date
December 31, 2015
Enrollment
634 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney failure, acute kidney injury, adverse drug reaction, kidney disease, kidney failure